Trial Profile
Exploratory clinical study of apatinib mesylate tablets in the treatment of EGFR negative patients with non squamous non-small cell lung cancer.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Nov 2016
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Cisplatin; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 22 Nov 2016 New trial record